1. Home
  2. NVCT vs THCP Comparison

NVCT vs THCP Comparison

Compare NVCT & THCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • THCP
  • Stock Information
  • Founded
  • NVCT 2020
  • THCP 2021
  • Country
  • NVCT United States
  • THCP United States
  • Employees
  • NVCT N/A
  • THCP N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • THCP
  • Sector
  • NVCT Health Care
  • THCP
  • Exchange
  • NVCT Nasdaq
  • THCP NYSE
  • Market Cap
  • NVCT 119.4M
  • THCP 100.5M
  • IPO Year
  • NVCT 2022
  • THCP 2021
  • Fundamental
  • Price
  • NVCT $8.07
  • THCP $10.60
  • Analyst Decision
  • NVCT Strong Buy
  • THCP
  • Analyst Count
  • NVCT 1
  • THCP 0
  • Target Price
  • NVCT $21.00
  • THCP N/A
  • AVG Volume (30 Days)
  • NVCT 104.8K
  • THCP 2.0K
  • Earning Date
  • NVCT 11-06-2024
  • THCP 01-01-0001
  • Dividend Yield
  • NVCT N/A
  • THCP N/A
  • EPS Growth
  • NVCT N/A
  • THCP N/A
  • EPS
  • NVCT N/A
  • THCP N/A
  • Revenue
  • NVCT N/A
  • THCP N/A
  • Revenue This Year
  • NVCT N/A
  • THCP N/A
  • Revenue Next Year
  • NVCT N/A
  • THCP N/A
  • P/E Ratio
  • NVCT N/A
  • THCP N/A
  • Revenue Growth
  • NVCT N/A
  • THCP N/A
  • 52 Week Low
  • NVCT $5.85
  • THCP $10.21
  • 52 Week High
  • NVCT $12.10
  • THCP $10.64
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 79.50
  • THCP 76.86
  • Support Level
  • NVCT $6.40
  • THCP $10.54
  • Resistance Level
  • NVCT $6.65
  • THCP $10.57
  • Average True Range (ATR)
  • NVCT 0.39
  • THCP 0.01
  • MACD
  • NVCT 0.21
  • THCP 0.01
  • Stochastic Oscillator
  • NVCT 94.14
  • THCP 100.00

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About THCP THUNDER BRDG CAP PARTNERS IV INC

Thunder Bridge Capital Partners IV Inc is a blank check company.

Share on Social Networks: